Briefs: Russia’s POISK-IT selects Autonomy as partner; Innova wins €0.5m grant
Autonomy Corporation plc, specialists in infrastructure software for the enterprise, said one of the leading Russian Systems Integrators Sci-Tech Centre POISK-IT, member of INLINE Technologies Group which specializes in the development, integration and implementation of next-generation information systems, has selected Autonomy as preferred vendor for pan-enterprise search solutions.
POISK-IT will become Autonomy's preferred partner in Russia. Autonomy's unique ability to form a conceptual understanding of all enterprise data will enable POISK-IT's customers to maximize the value of their corporate data, while mitigating the risks associated with the access, retrieval and management of information.
"The Russian market is maturing as organizations increasingly realize the opportunities and risks associated with the staggering growth of unstructured information," said Alexey Lubimov, director general at POISK-IT.
"Unlike other approaches, Autonomy's IDOL technology forms an understanding of the meaning of information and boasts hundreds of functions to process that information quickly and accurately. This unique technology coupled with POISK-IT's expertise will bring tremendous benefits to organizations in the region."
&
Cambridge Consultants has developed Centaur, a comprehensive GSM/ GPRS/ EDGE/ E-EDGE physical layer (PHY) reference design, enabling the next generation of low-cost cellular base-stations and femtocells to incorporate mass-market 2G and 2.75G capabilities. The reference design includes a framework model and code implemented on the picoArray from picoChip, the market leading baseband platform for femtocells and software defined base-stations.
Cambridge Consultants said the GSM standard supports over 3 billion mobile users worldwide and accounts for more than 80% of the global mobile telecommunications user base, yet many new low-cost base-stations like femtocells do not offer GSM services.
"While the benefits of advanced generation network standards like 3G and WiMax are well known, base-stations that do not enable 2G GSM network access are creating a barrier to adoption by the vast majority of the existing user base of GSM," the company said.
"Similarly, the adoption of GSM by the next billion users is seen as needing even lower cost infrastructure than is available today after nearly 20 years of product evolution."
&
Innova Biosciences Ltd, specialists in bioconjugation, has been awarded €455,000 of a €3m European grant. Through the PROACTIVE consortium, a high throughput plasma screening platform will be developed for the discovery of biomarkers of early stage cancer.
Innova has had success with its range of Lightning-Link bioconjugation products, which provide a simple way for joining biomolecules, a process carried out in thousands of research laboratories worldwide. Innova's participation in the PROACTIVE consortium - along with Olink, Copenhagen University, Fujirebio Diagnostics AB, Uppsala University, and Integromics S.L - to develop immunodiagnostics reagents will help cement the company's position as a world leader in bioconjugation technology, the Cambridge-based company said.
&
Cambridge Consultants said Pamela McNamara has joined the company's U.S. business in the position of President, in which role she will lead work in high technology product and systems development for clients in the medtech, wireless, defence and cleantech sectors.
Previously, Ms McNamara was CEO of CRF Inc., an electronic patient reported outcomes technology company providing global wireless data collection solutions for the life sciences industry. She was also with Arthur D. Little for more than 20 years, holding a number of senior technology and management positions in Global Health Care, eventually serving as CEO of the entire organization.
